- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06210009
Effect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease
January 12, 2026 updated by: Joseph Crivelli, University of Alabama at Birmingham
Effect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease: A Randomized Controlled Trial (CARDIA Ancillary Study)
The true capacity for a healthy diet to improve urinary stone risk factors is not well-defined.
The objective of this study is to measure the effect of adopting a healthy dietary pattern on kidney stone disease (KSD) risk.
The working hypothesis is that a Dietary Approaches to Stop Hypertension (DASH)-style diet will improve 24-hour urine stone risk parameters.
The approach to testing this hypothesis will be to randomize participants with KSD to a standardized DASH-style vs. Western-style diet for one week.
The Bionutrition Unit of the Center for Clinical and Translational Science will provide all meals to participants.
The rationale for this study is that by measuring the effect of a DASH-style diet on urinary stone risk parameters, a benchmark for future real-world, implementation studies will be established.
Based on available evidence, this will be the first controlled diet study to assess the DASH dietary pattern for improving urinary stone risk parameters.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Joseph Crivelli, MD
- Phone Number: 205-996-8765
- Email: crivelli@uab.edu
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- Recruiting
- University of Alabama at Birmingham
-
Contact:
- Joseph Crivelli, MD
- Phone Number: 205-996-8765
- Email: crivelli@uab.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Birmingham, AL area participants of the Coronary Artery Risk Development in Young Adults (CARDIA) study OR patients of the University of Alabama at Birmingham/Kirklin Clinic
- Self-reported, documented, and/or prior imaging-based diagnosis of kidney stone disease
- Age 19-89
- Any sex
- Any race
- Able to provide informed consent
- Willing to perform 24-hour urine collections
- Willing to consume meals prepared by Bionutrition Unit
- No food allergies/intolerance to any of the foods in the study menus
- Willing to stop for 7 days before and during study: Multivitamins and/or Dietary supplements (including calcium and vitamin C)
Exclusion Criteria:
- Dialysis
- Kidney transplant recipient
- Estimated glomerular filtration rate (eGFR) <60 ml/min/1.73m2 based on historical laboratory measurements
- Renal tubular acidosis
- Current use of acetazolamide, topiramate, or zonisamide
- Primary hyperparathyroidism or history of parathyroidectomy
- Hyperthyroidism
- Sarcoidosis
- Primary hyperoxaluria
- Cystinuria
- Nephrotic syndrome
- Malabsorptive conditions including inflammatory bowel disease or history of malabsorptive surgery (e.g., Roux-en-Y gastric bypass, small bowel resection)
- Urinary retention requiring catheterization
- Urinary diversion
- Pregnancy
- Breastfeeding
- Malignancy treated in the past 12 months other than non-melanoma skin cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: DASH-Style Diet
For seven days, participants will consume a diet characterized by higher intake of fruits, vegetables, and low-fat dairy, in addition to whole grains, poultry, fish, and nuts, but smaller amounts of red meat, sweets, and sugar-containing beverages.
|
Participants will be randomized to a DASH-style diet
|
|
Other: Western-Style Diet
For seven days, participants will consume a diet characterized by characterized by higher intake of red meat, sweets, and items containing added sugar, processed starches, and seed oils, in addition to lower intake of fruits, vegetables, and low-fat dairy.
|
Participants will be randomized to a Western-style diet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference between the two arms in supersaturation of calcium oxalate
Time Frame: Days 6-7 of the assigned intervention
|
Supersaturation of calcium oxalate is an index reflecting the propensity for the formation and growth of the most common stone type (calcium oxalate), which is calculated using excretion rates including urinary volume, calcium, citrate, and oxalate.
|
Days 6-7 of the assigned intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference between the two arms in supersaturation of calcium oxalate between the baseline and intervention periods
Time Frame: Days 6-7 of the assigned intervention
|
This secondary outcome will be calculated using a difference in differences approach.
|
Days 6-7 of the assigned intervention
|
|
Difference between the two arms in supersaturation of uric acid
Time Frame: Days 6-7 of the assigned intervention
|
Supersaturation of uric acid is an index reflecting the propensity for the formation and growth of uric acid stones.
|
Days 6-7 of the assigned intervention
|
|
Difference between the two arms in supersaturation of calcium phosphate
Time Frame: Days 6-7 of the assigned intervention
|
Supersaturation of calcium phosphate is an index reflecting the propensity for the formation and growth of calcium phosphate stones.
|
Days 6-7 of the assigned intervention
|
|
Difference between the two arms in urine volume
Time Frame: Days 6-7 of the assigned intervention
|
Low urine volume is a stone risk factor.
|
Days 6-7 of the assigned intervention
|
|
Difference between the two arms in urine calcium
Time Frame: Days 6-7 of the assigned intervention
|
High urine calcium is a stone risk factor.
|
Days 6-7 of the assigned intervention
|
|
Difference between the two arms in urine oxalate
Time Frame: Days 6-7 of the assigned intervention
|
High urine oxalate is a stone risk factor.
|
Days 6-7 of the assigned intervention
|
|
Difference between the two arms in urine citrate
Time Frame: Days 6-7 of the assigned intervention
|
Low urine citrate is a stone risk factor.
|
Days 6-7 of the assigned intervention
|
|
Difference between the two arms in urine uric acid
Time Frame: Days 6-7 of the assigned intervention
|
High urine uric acid is a stone risk factor.
|
Days 6-7 of the assigned intervention
|
|
Difference between the two arms in urine pH
Time Frame: Days 6-7 of the assigned intervention
|
Urine pH can influence stone formation and growth.
|
Days 6-7 of the assigned intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 6, 2025
Primary Completion (Estimated)
August 31, 2027
Study Completion (Estimated)
August 31, 2027
Study Registration Dates
First Submitted
January 4, 2024
First Submitted That Met QC Criteria
January 13, 2024
First Posted (Actual)
January 18, 2024
Study Record Updates
Last Update Posted (Actual)
January 13, 2026
Last Update Submitted That Met QC Criteria
January 12, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Urogenital Diseases
- Male Urogenital Diseases
- Calculi
- Pathological Conditions, Anatomical
- Kidney Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urolithiasis
- Urinary Calculi
- Nephrolithiasis
- Pathological Conditions, Signs and Symptoms
- Kidney Calculi
Other Study ID Numbers
- IRB-300012217
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Stone
-
Washington University School of MedicineRecruiting
-
Société Internationale d'UrologieCompletedStone Ureter | Stone, Kidney | Stone;RenalUnited States, China, Korea, Republic of, Malaysia, Saudi Arabia, Greece, India, Indonesia, Iran, Islamic Republic of, Iraq, Kenya, Romania, South Africa, Taiwan, Turkey
-
Wake Forest University Health SciencesCogenix Medical CorporationWithdrawnKidney Stone | Renal Stone | Ureter StoneUnited States
-
Advance Shockwave Technology GmbHUnknownKidney StonesUnited States
-
Ain Shams UniversityRecruitingStone, Kidney | Stone Clearance | Stone, Urinary | Stone;RenalEgypt
-
Kırıkkale UniversityCompletedKidney Calculi Nephrolithiasis Urolithiasis Renal Stone
-
University of British ColumbiaActive, not recruiting
-
Selcuk UniversityThe Scientific and Technological Research Council of TurkeySuspendedKidney StonesTurkey
-
Mansoura UniversityCompleted
-
Mansoura UniversityUnknownUrologic Diseases | Stones, Kidney | Stone, Urinary | Shock Wave LithotripsyEgypt
Clinical Trials on DASH-Style Diet
-
National Health Research Institutes, TaiwanTaipei Veterans General Hospital, TaiwanUnknown
-
University of MichiganTerminatedDiastolic Heart Failure | Hypertensive Heart DiseaseUnited States
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Case Western Reserve UniversityCompleted
-
Duke UniversityCompletedHypertension | Chronic Kidney DiseaseUnited States
-
Assiut UniversityNot yet recruitingDyslipidemia Associated With Type II Diabetes Mellitus
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedHypertension | Diabetes | Insulin ResistanceUnited States
-
Penn State UniversityNational Cattlemen's Beef AssociationCompletedCardiovascular Disease | Metabolic SyndromeUnited States
-
Purdue UniversityCompletedHypertension | DyslipidemiasUnited States
-
University of MichiganCompletedDiastolic Heart Failure | Hypertensive Heart DiseaseUnited States